[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1411422A - Methods for purifying urokinase preparations - Google Patents

Methods for purifying urokinase preparations

Info

Publication number
GB1411422A
GB1411422A GB1550275A GB1550275A GB1411422A GB 1411422 A GB1411422 A GB 1411422A GB 1550275 A GB1550275 A GB 1550275A GB 1550275 A GB1550275 A GB 1550275A GB 1411422 A GB1411422 A GB 1411422A
Authority
GB
United Kingdom
Prior art keywords
urokinase
solution
conductivity
micromhos
ammonium sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1550275A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7134435A external-priority patent/FR2153200A1/en
Priority claimed from FR7223868A external-priority patent/FR2190413A2/en
Priority claimed from FR7223867A external-priority patent/FR2190412A1/en
Application filed by Choay SA filed Critical Choay SA
Publication of GB1411422A publication Critical patent/GB1411422A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1411422 Purifying urokinase solutions CHOAY SA 22 Sept 1972 [24 Sept 1971 30 June 1972 (2)] 15502/75 Divided out of 1411421 Heading C3H A method of purifying an aqueous solution containing 1.5-3 mg./ml. of urokinase, foreign proteins and pyrogenic substances involves adjusting the pH of the solution to between 3 and 4.5 and its conductivity to between 15,000 and 25,000 micromhos/cm., determining, e.g. with the aid of a graph prepared from experimental results, the concentration of ammonium suplate needed for forming a precipitate of foreign proteins &c. containing only 2-5% of the total activity of the urokinase in the initial solution, adding to the solution the appropriate quantity of ammonium sulphate and collecting the supernatant. The concentration of ammonium sulphate employed should preferably correspond to a degree of saturation of the solution of from 0.25 to 0.35. The urokinase is then precipitated out with a further quantity of ammonium sulphate and the precipitate is dissolved in distilled, sterile apyrogenic water at pH 7. The initial urokinase solution may be obtained from human urine by absorbing the proteins &c. from the urine on a filtration adjuvant, re-extracting the urokinase and other adsorbed proteins &c. therefrom, salting out urokinase from the solution by adding ammonium sulphate, dissolving the resulting precipitate in a glucose solution and dialysing the latter to obtain a concentrated crudeurokinase solution of specified conductivity, two steps of fractionation using diethylaminoethyl cellulose employing in the first step solutions of pH 4-6 and conductivity 15,000- 25,000 micromhos/cm. with 15-40 g. of resin per 14 million CTA units of urokinase, and in the second step solutions of pH 6-7 and conductivity 15,000-18,000 micromhos/cm. with 30-60 g. of resin per 10 million CTA units of the enzyme, the urokinase-containing medium during the second step being diluted with quantities of water sufficient to lower the conductivity by about 1000 micromhos/cm. at each successive dilution until a conductivity of about 9000 micromhos/cm. is reached, and then absorbing the urokinase in the solution obtained by combining the effluent and the washing liquors from the resin used in the second fractionation on either carboxymethyl cellulose at a pH of about 5 and eluting the adsorbed urokinase using a phosphate buffer at pH 6.8-6.9, or kaolin at pH 6.2 and eluting the urokinase retained with a solution of ammonium chloride in 4% ammonia, followed by precipitation with ammonium sulphate and dialysis against a 0.05 M phosphate solution buffered to pH 6.2.
GB1550275A 1971-09-24 1972-09-22 Methods for purifying urokinase preparations Expired GB1411422A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR7134435A FR2153200A1 (en) 1971-09-24 1971-09-24 Stable,pyrogen-free urokinase prepns - from human urine
FR7223868A FR2190413A2 (en) 1972-06-30 1972-06-30 Stable,pyrogen-free urokinase prepns - from human urine
FR7223867A FR2190412A1 (en) 1972-06-30 1972-06-30 Stable,pyrogen-free urokinase prepns - from human urine

Publications (1)

Publication Number Publication Date
GB1411422A true GB1411422A (en) 1975-10-22

Family

ID=27249660

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1550275A Expired GB1411422A (en) 1971-09-24 1972-09-22 Methods for purifying urokinase preparations
GB4400372A Expired GB1411421A (en) 1971-09-24 1972-09-22 Urokinaseheparin complex

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4400372A Expired GB1411421A (en) 1971-09-24 1972-09-22 Urokinaseheparin complex

Country Status (11)

Country Link
JP (1) JPS5718465B2 (en)
BE (1) BE789189A (en)
CA (1) CA986013A (en)
CH (2) CH560050A5 (en)
DE (1) DE2246969C2 (en)
DK (1) DK133130C (en)
ES (3) ES406980A1 (en)
GB (2) GB1411422A (en)
IN (1) IN141112B (en)
NL (1) NL7212891A (en)
SE (2) SE405806B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428248B2 (en) * 1973-07-24 1978-01-12 Serna Ag, Glarus (Schweiz) PROCESS FOR PRODUCING PYROGEN-FREE UROKINASE
US3957582A (en) * 1974-11-20 1976-05-18 Abbott Laboratories Purification of urokinase
JPS59143694U (en) * 1983-03-14 1984-09-26 東洋電機製造株式会社 Automatic drawing cutting machine press ruling device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256158A (en) * 1963-03-22 1966-06-14 Abbott Lab Purification of urokinase
US3355361A (en) * 1964-10-15 1967-11-28 Sterling Drug Inc Recovery and purification of urokinase
US3477912A (en) * 1967-07-07 1969-11-11 Century Lab Inc Method of production of urokinase
US3477913A (en) * 1967-10-31 1969-11-11 Century Lab Inc Method of production of urokinase

Also Published As

Publication number Publication date
ES406980A1 (en) 1976-06-16
GB1411421A (en) 1975-10-22
NL7212891A (en) 1973-03-27
JPS4856888A (en) 1973-08-09
ES440244A1 (en) 1977-08-01
IN141112B (en) 1977-01-22
CH560050A5 (en) 1975-03-27
DK133130C (en) 1976-09-27
BE789189A (en) 1973-03-22
DK133130B (en) 1976-03-29
CA986013A (en) 1976-03-23
JPS5718465B2 (en) 1982-04-16
SE405806B (en) 1979-01-08
DE2246969A1 (en) 1973-04-05
DE2246969C2 (en) 1986-12-11
SE7514792L (en) 1975-12-30
ES455975A1 (en) 1978-03-01
CH604726A5 (en) 1978-09-15

Similar Documents

Publication Publication Date Title
US4343736A (en) Process for recovering interferon
ATE51754T1 (en) METHOD OF SELECTIVE ADSORPTION OF HEPARIN.
GB1356911A (en) Purification and fractionation of carcinoembryonic antigen
US3810820A (en) Urate oxidase and process for the production thereof
Kaji et al. Purification and properties of an unusually acid-stable endo-polygalacturonase produced by Corticium rolfsii
DE1642660A1 (en) Process for the production of urokinase
US3897309A (en) Process for removing pyrogenic material from aqueous solutions
DE2220568A1 (en) New affinity matrix material and its uses
GB1411422A (en) Methods for purifying urokinase preparations
JPS60258123A (en) Method of obtaining factor xiii specimen and use
CN106520739A (en) Method using affinity chromatography to purify urokinase
US3475276A (en) Method of producing uricase from yeast
FR2577048B1 (en) REAGENT FOR THE HEMAGGLUTINATION DETERMINATION OF ANTIBODIES AGAINST BACTERIAL TOXINS, METHOD OF PREPARATION AND ITS APPLICATION
Hasegawa et al. Further evidence for the existence of angiotensinogen stimulating activity (ASA) after nephrectomy
Castle et al. Purification of rennin
US3477912A (en) Method of production of urokinase
US3269918A (en) Process for the production of purified glucose oxidase
CN106520737A (en) Method for purifying urokinase through resin regeneration column efficiency improvement
GB1060513A (en) Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase
WO1983001899A1 (en) Process for the production of human gamma-interferon
JPH0439380B2 (en)
EP0025508B1 (en) Process for the preparation of the third component of the complement as made from human blood plasma
CH525251A (en) Aspergillopeptidase ARL 1 - new enzyme preparation with anti blood clotting properties
US2937120A (en) Process for obtaining intrinsic factor
PL85201B1 (en)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee